Please note that the URL for this site has changed to a '' address from ''. This reflects changes we have made to hosting for this site.
Current UK NSC recommendations > Asymptomatic bacteriuria

The UK NSC recommendation on Asymptomatic Bacteriuria screening in pregnancy (currently in consultation)


This recommendation is currently being reviewed as part of the UK NSC's regular review cycle of all policies.

The review process began in Mar 2016 and is estimated to be completed by Mar 2017.

» Download the expert review for Asymptomatic bacteriuria (PDF document, 785KB)

The UK NSC welcomes comments and feedback on the expert review during the consultation period that lasts from 27/10/2016 until 23/01/2017. Please send comments to Screening Evidence by e-mail using this feedback form.

Please note that all consultation submissions will be published on this page when the review is complete. Full details can be found in the confidentiality and disclosure section at the bottom of this page.

Recommendation Systematic population screening programme not recommended, clinical practice guidelines covered by NICE

Screening for asymptomatic bacteriuria should be offered as part of routine antenatal care packages.

The UK NSC is concerned about the lack of knowledge about the current prevalence of asymptomatic bacteriuria, the impact of screening on pyelonephritis as a whole, the optimum test, its timing and frequency during the pregnancy and the optimum treatment strategy.  However current practice overlaps with guidance in other areas and the consequences of recommending withdrawal of screening are uncertain at this point.


Find general information about population health screening.

More about Asymptomatic bacteriuria

This is a condition caused by bacteria in the urine and is also known as urinary tract infection. These infections are common during pregnancy.

» Read more about urinary tract infection on NHS Choices


Group B Strep Support
Royal College of Obstetricians and Gynaecologists
UCL Elizabeth Garrett Anderson Institute for Women’s Health

The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.

Related documents

icon Antenatal Screening for Asymptomatic Bacteriuria Policy Review Summary (PDF document, 165KB, 28/05/12)

Confidentiality and disclosure

Information provided in response to this consultation, including personal information, may be subject to publication or release to other parties or to disclosure in accordance with the access to information regimes (these are primarily the Freedom of Information Act 2000, the Data Protection Act 1998, and the Environmental Information Regulations 2004). If you want information, including personal data that you provide to be treated as confidential, please be aware that, under the FOIA, there is a statutory Code of Practice with which public authorities must comply and which deals, amongst other things, with obligations of confidence.

In view of this it would be helpful if you could explain to us why you regard the information you have provided as confidential. If we receive a request for disclosure of the information we will take full account of your explanation, but we cannot give an assurance that confidentiality can be maintained in all circumstances. An automatic confidentiality disclaimer generated by your IT system will not, of itself, be regarded as binding on the UK National Screening Committee.

Any request for information to be treated in confidence will be taken into consideration in the publication of responses to the consultation. The UK National Screening Committee intends to publish all responses following the closure of the consultation period, however we will not publish responses from respondents who request that any of the information in their response, including personal data, should be handled in confidence. The UK National Screening Committee reserves the right not to publish or take into account any representations which are openly offensive or defamatory.

More options

Go to top